Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Vásquez, Carol E.
Riener, Romina
Reynolds, Elaine
and
Britton, Gabrielle B.
2014.
NMDA receptor dysregulation in chronic state: A possible mechanism underlying depression with BDNF downregulation.
Neurochemistry International,
Vol. 79,
Issue. ,
p.
88.
Graef, John D
Newberry, Kimberly
Newton, Amy
Pieschl, Rick
Shields, Eric
Luan, Fu-ni
Simmermacher, Jean
Luchetti, David
Schaeffer, Eric
Li, Yu-Wen
Kiss, Laszlo
and
Bristow, Linda J
2015.
Effect of acute NR2B antagonist treatment on long-term potentiation in the rat hippocampus.
Brain Research,
Vol. 1609,
Issue. ,
p.
31.
El Iskandrani, Kareem S
Oosterhof, Chris A
El Mansari, Mostafa
and
Blier, Pierre
2015.
Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons.
Journal of Psychopharmacology,
Vol. 29,
Issue. 7,
p.
792.
Romine, Jennifer
Gao, Xiang
Xu, Xiao-Ming
So, Kwok Fai
and
Chen, Jinhui
2015.
The proliferation of amplifying neural progenitor cells is impaired in the aging brain and restored by the mTOR pathway activation.
Neurobiology of Aging,
Vol. 36,
Issue. 4,
p.
1716.
Newport, D. Jeffrey
Carpenter, Linda L.
McDonald, William M.
Potash, James B.
Tohen, Mauricio
and
Nemeroff, Charles B.
2015.
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.
American Journal of Psychiatry,
Vol. 172,
Issue. 10,
p.
950.
Tang, Juanjuan
Xue, Wenda
Xia, Baomei
Ren, Li
Tao, Weiwei
Chen, Chang
Zhang, Hailou
Wu, Ruyan
Wang, Qisheng
Wu, Haoxin
Duan, Jinao
and
Chen, Gang
2015.
Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice.
Scientific Reports,
Vol. 5,
Issue. 1,
Costa, Veronica
Lugert, Sebastian
and
Jagasia, Ravi
2015.
Cognitive Enhancement.
Vol. 228,
Issue. ,
p.
99.
Liu, Xiao-Long
Luo, Liu
Mu, Rong-Hao
Liu, Bin-Bin
Geng, Di
Liu, Qing
and
Yi, Li-Tao
2015.
Fluoxetine regulates mTOR signalling in a region-dependent manner in depression-like mice.
Scientific Reports,
Vol. 5,
Issue. 1,
Hillhouse, Todd M.
Merritt, Christina R.
and
Porter, Joseph H.
2015.
Effects of the noncompetitive N-methyl-D-aspartate receptor antagonist ketamine on visual signal detection performance in rats.
Behavioural Pharmacology,
Vol. 26,
Issue. 5,
p.
495.
Donoghue, Anna C.
Roback, Mark G.
and
Cullen, Kathryn R.
2015.
Remission From Behavioral Dysregulation in a Child With PTSD After Receiving Procedural Ketamine.
Pediatrics,
Vol. 136,
Issue. 3,
p.
e694.
Sałat, Kinga
Siwek, Agata
Starowicz, Gabriela
Librowski, Tadeusz
Nowak, Gabriel
Drabik, Urszula
Gajdosz, Ryszard
and
Popik, Piotr
2015.
Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor.
Neuropharmacology,
Vol. 99,
Issue. ,
p.
301.
Engers, Julie L.
Rodriguez, Alice L.
Konkol, Leah C.
Morrison, Ryan D.
Thompson, Analisa D.
Byers, Frank W.
Blobaum, Anna L.
Chang, Sichen
Venable, Daryl F.
Loch, Matthew T.
Niswender, Colleen M.
Daniels, J. Scott
Jones, Carrie K.
Conn, P. Jeffrey
Lindsley, Craig W.
and
Emmitte, Kyle A.
2015.
Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents.
Journal of Medicinal Chemistry,
Vol. 58,
Issue. 18,
p.
7485.
Bonnet, Udo
2015.
Long-Term Ketamine Self-Injections in Major Depressive Disorder: Focus on Tolerance in Ketamine’s Antidepressant Response and the Development of Ketamine Addiction.
Journal of Psychoactive Drugs,
Vol. 47,
Issue. 4,
p.
276.
Dutta, Arpan
McKie, Shane
and
Deakin, J.F. William
2015.
Ketamine and other potential glutamate antidepressants.
Psychiatry Research,
Vol. 225,
Issue. 1-2,
p.
1.
Manosso, Luana M.
Moretti, Morgana
Ribeiro, Camille M.
Gonçalves, Filipe M.
Leal, Rodrigo B.
and
Rodrigues, Ana Lúcia S.
2015.
Antidepressant-like effect of zinc is dependent on signaling pathways implicated in BDNF modulation.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 59,
Issue. ,
p.
59.
Rajkumar, R.
Fam, J.
Yeo, E.Y.M.
and
Dawe, G.S.
2015.
Ketamine and suicidal ideation in depression: Jumping the gun?.
Pharmacological Research,
Vol. 99,
Issue. ,
p.
23.
Zhang, Ji-chun
Yao, Wei
Dong, Chao
Yang, Chun
Ren, Qian
Ma, Min
Han, Mei
and
Hashimoto, Kenji
2015.
Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.
Psychopharmacology,
Vol. 232,
Issue. 23,
p.
4325.
Fuller, Jasmine J.L.
Murray, Ryan C.
and
Horner, Kristen A.
2015.
d-amphetamine withdrawal-induced decreases in brain-derived neurotrophic factor in sprague-dawley rats are reversed by treatment with ketamine.
Neuropharmacology,
Vol. 97,
Issue. ,
p.
7.
Cunha, Mauricio P.
Pazini, Francis L.
Ludka, Fabiana K.
Rosa, Julia M.
Oliveira, Ágatha
Budni, Josiane
Ramos-Hryb, Ana B.
Lieberknecht, Vicente
Bettio, Luis E. B.
Martín-de-Saavedra, Maria D.
López, Manuela G.
Tasca, Carla I.
and
Rodrigues, Ana Lúcia S.
2015.
The modulation of NMDA receptors and l-arginine/nitric oxide pathway is implicated in the anti-immobility effect of creatine in the tail suspension test.
Amino Acids,
Vol. 47,
Issue. 4,
p.
795.
Szewczyk, Bernadeta
Pochwat, Bartłomiej
Rafało, Anna
Palucha-Poniewiera, Agnieszka
Domin, Helena
and
Nowak, Gabriel
2015.
Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc.
Neuropharmacology,
Vol. 99,
Issue. ,
p.
517.
Comments
No Comments have been published for this article.